How Does Basaglar Work? Mechanism of Action Explained in Plain English

If you've been prescribed Basaglar, you may be wondering: how exactly does this insulin work, and why does it last so long? Understanding the basics of how Basaglar works can help you use it more effectively, recognize when something might be wrong, and feel more confident in your diabetes management plan.

The Problem Basaglar Solves: What Happens in Diabetes

In a healthy body, the pancreas continuously releases small amounts of insulin into the bloodstream — a background level called "basal" insulin — to keep blood sugar stable between meals and overnight. This background insulin allows your cells to absorb glucose from the blood for energy.

In Type 1 diabetes, the immune system destroys the insulin-producing beta cells in the pancreas, so the body makes little or no insulin at all. In Type 2 diabetes, the pancreas doesn't produce enough insulin and/or the body's cells don't respond to it properly (insulin resistance). In both cases, without enough insulin, blood sugar rises to dangerous levels.

Basaglar replaces the basal insulin function — providing a steady, background level of insulin activity throughout the day.

What Is Basaglar Made Of?

Basaglar is insulin glargine — a synthetic (laboratory-made) version of human insulin with slight modifications to its amino acid structure. Specifically, two changes were made compared to natural human insulin:

1. An asparagine amino acid at position 21 of the A-chain was replaced with glycine.
2. Two arginine amino acids were added to the end of the B-chain.

These structural changes shift insulin glargine's behavior at the body's physiological pH. While regular insulin dissolves quickly in blood and acts fast, insulin glargine forms microscopic deposits under the skin after injection — releasing slowly and steadily into the bloodstream over many hours.

How Basaglar Lowers Blood Sugar

Once Basaglar is absorbed into the bloodstream, it works in three main ways:

1. Stimulates glucose uptake by muscles and fat: Insulin acts like a key that unlocks cells — allowing them to absorb glucose from the blood and use it for energy. Skeletal muscle and fat tissue are the primary sites of insulin-stimulated glucose uptake.
2. Reduces liver glucose production: The liver continuously produces glucose even between meals (a process called gluconeogenesis and glycogenolysis). Insulin inhibits this process, preventing the liver from flooding the blood with extra sugar — especially important overnight.
3. Suppresses fat and protein breakdown: Insulin inhibits lipolysis (fat breakdown) and proteolysis (protein breakdown), while also encouraging protein synthesis. This is why people with poorly controlled diabetes lose muscle and fat — and why starting insulin often causes modest weight gain.

Why Does Basaglar Last 24 Hours?

The key to Basaglar's long duration is its behavior after injection. The formulation is slightly acidic (pH ~4) to keep the insulin in solution inside the pen. Once injected into the slightly alkaline environment under the skin (subcutaneous tissue, pH ~7.4), the insulin glargine becomes less soluble and precipitates into tiny depot crystals.

These microscopic crystals slowly dissolve and release insulin glargine molecules into the bloodstream over approximately 24 hours. The release is relatively steady with no pronounced peak — unlike intermediate-acting insulins like NPH, which have a distinct peak of action several hours after injection. This flat, peakless profile is why Basaglar is given just once a day and why it has a lower risk of nocturnal hypoglycemia compared to older basal insulins.

When Does Basaglar Start Working?

Basaglar begins lowering blood sugar approximately 90 minutes after injection, reaches a relatively steady state of glucose-lowering activity, and continues working for up to 24 hours. The onset (90 minutes) is slower than rapid-acting insulins (which work in 10–15 minutes) and the duration is much longer. This is why Basaglar is a "basal" insulin — it provides background coverage, not meal coverage.

How Is Basaglar Different from Toujeo and Tresiba?

Basaglar uses the same active molecule (insulin glargine) as Lantus and Rezvoglar, at the standard U-100 concentration. Toujeo uses insulin glargine at U-300 (3x concentrated), which has a slightly longer and flatter action curve. Tresiba (insulin degludec) uses a completely different molecule that forms long chains under the skin and releases over more than 42 hours — giving even more dosing flexibility but a different pharmacokinetic profile than Basaglar.

For a full overview of Basaglar uses and dosing instructions, see our guide: What is Basaglar? Uses, dosage, and what you need to know. If you need to find a pharmacy that has Basaglar in stock near you, medfinder can help.